Microbot Medical (FRA:CY9D) Beta: 1.6410 (As of Jul. 01, 2026)


FRA:CY9D Microbot Medical Inc FRA:CY9D
32 GF Score
Price €1.61
! 2 Warning Signs
View Full Analysis

What is Microbot Medical Beta?

Microbot Medical FRA:CY9D +4.89% 32 Beta is 1.6410 as of Jul. 01, 2026. GuruFocus rates FRA:CY9D with a GF Score™ of 32/100. The stock has 2 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-01), Microbot Medical's Beta is 1.6410.


Microbot Medical  (FRA:CY9D) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Microbot Medical Beta Related Terms


Microbot Medical Beta Historical Data

* Premium members only.

The historical data trend for Microbot Medical's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbot Medical Beta Chart

Microbot Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.02 0.94 1.31 0.24 2.26

Microbot Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.68 1.26 2.26 1.09

FRA:CY9D vs STXS, POCI, DXR: Beta Comparison

For the Medical Instruments & Supplies subindustry, Microbot Medical's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbot Medical Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Microbot Medical's Beta distribution charts can be found below:

* The bar in red indicates where Microbot Medical's Beta falls into.


FRA:CY9D
32GF Score
Microbot Medical Inc FRA:CY9D
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microbot Medical Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.6410 mean?
Microbot Medical (FRA:CY9D) has a Beta of 1.6410 as of Jul. 01, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Microbot Medical and its competitors.
Is Microbot Medical's Beta too high?
Microbot Medical's current Beta is 1.6410. Overall, Microbot Medical has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Microbot Medical's Beta compare to STXS and POCI?
Microbot Medical's Beta of 1.6410 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Microbot Medical and its competitors. Microbot Medical's current Beta is 1.6410. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbot Medical stock overvalued right now?
Microbot Medical (FRA:CY9D) has a current Beta of 1.6410. The current Beta is 1.6410. Microbot Medical's overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Microbot Medical (FRA:CY9D), the current Beta is 1.6410 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Microbot Medical Business Description

Other Exchanges MBOT:USA
Address 175 Derby Street, Building 27, Hingham, MA, USA, 02043
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
32GF Score

Get the complete analysis for FRA:CY9D

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.61
Price